CGON
CG Oncology Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +8.3% ·
aandelenstroom -7.7% ·
netto nieuwe posities +7.7%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +7 | 45.64M | $3.24B | +12 | −5 |
| Q1 2026 | 90 | +11 | 42.64M | $2.85B | +15 | −4 |
| Q4 2025 | 77 | 0 | 47.85M | $1.99B | — | — |
| Q3 2025 | 16 | 0 | 30.32M | $1.22B | +1 | −1 |
| Q2 2025 | 13 | +1 | 24.41M | $634.75M | +2 | −1 |
| Q1 2025 | 9 | 0 | 12.23M | $299.43M | +1 | −1 |
| Q4 2024 | 9 | +1 | 9.32M | $267.32M | +1 | — |
| Q3 2024 | 7 | -2 | 3.66M | $137.92M | — | −2 |
| Q2 2024 | 9 | — | 2.48M | $78.32M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 5.91M | — | $153.57M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 5.91M | — | $153.57M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 5.91M | — | $153.57M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 5.91M | — | $153.57M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 5.91M | — | $153.57M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 4.46M | — | $115.87M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Fidelity (FMR) ✦ | 3.86M | — | $100.26M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 3.86M | — | $100.26M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 3.86M | — | $100.26M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 2.17M | +10.1% | $56.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 2.01M | +98.5% | $52.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 2.01M | +98.5% | $52.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 1.90M | -10.7% | $49.37M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 1.90M | -10.7% | $49.37M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 1.90M | -10.7% | $49.37M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 1.90M | -10.7% | $49.37M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 1.90M | -10.7% | $49.37M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 1.90M | -10.7% | $49.37M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.90M | -10.7% | $49.37M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | Point72 Asset Management ✦ | 1.48M | -11.5% | $38.36M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 31 | Geode Capital Management ✦ (passief) | 1.34M | +4.4% | $34.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Geode Capital Management ✦ (passief) | 1.34M | +4.4% | $34.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Millennium Management ✦ | 959.97K | +61.0% | $24.96M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 175.25K | -84.6% | $4.56M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 113.03K | +483.2% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 113.03K | +483.2% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 113.03K | +483.2% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 113.03K | +483.2% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Renaissance Technologies ✦ | 46.10K | Nieuw | $1.20M | 0.0% | New | 1 | SEC ↗ |
| 40 | D. E. Shaw & Co. ✦ | 10.50K | Nieuw | $273,000 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $1.20M | 0.0% |
| D. E. Shaw & Co. | $273,000 | 0.0% |
Verlaten
| Marshall Wace | $59.23M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 232 houders, 86.28M aandelen, $5.07B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 1.00K aand · $74,540
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie